TFC Financial Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.9K | Hold |
718
| – | – | ﹤0.01% | 291 |
|
|
2025
Q1 | $24.4K | Buy |
718
+40
| +6% | +$1.36K | ﹤0.01% | 307 |
|
|
2024
Q4 | $26.7K | Sell |
678
-80
| -11% | -$3.15K | ﹤0.01% | 291 |
|
|
2024
Q3 | $35.6K | Buy |
758
+58
| +8% | +$2.73K | 0.01% | 281 |
|
|
2024
Q2 | $37.8K | Hold |
700
| – | – | 0.01% | 255 |
|
|
2024
Q1 | $47.7K | Hold |
700
| – | – | 0.01% | 236 |
|
|
2023
Q4 | $43.8K | Buy |
700
+680
| +3,400% | +$42.6K | 0.01% | 237 |
|
|
2023
Q3 | $908 | Hold |
20
| – | – | ﹤0.01% | 537 |
|
|
2023
Q2 | $1.12K | Hold |
20
| – | – | ﹤0.01% | 503 |
|
|
2023
Q1 | $905 | Hold |
20
| – | – | ﹤0.01% | 517 |
|
|
2022
Q4 | $813 | Hold |
20
| – | – | ﹤0.01% | 480 |
|
|
2022
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 456 |
|
|
2022
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 448 |
|
|
2022
Q1 | $1K | Sell |
20
-269
| -93% | -$13.5K | ﹤0.01% | 468 |
|
|
2021
Q4 | $22K | Hold |
289
| – | – | 0.01% | 267 |
|
|
2021
Q3 | $32K | Hold |
289
| – | – | 0.01% | 232 |
|
|
2021
Q2 | $47K | Hold |
289
| – | – | 0.02% | 207 |
|
|
2021
Q1 | $35K | Hold |
289
| – | – | 0.01% | 213 |
|
|
2020
Q4 | $44K | Buy |
289
+20
| +7% | +$3.05K | 0.02% | 199 |
|
|
2020
Q3 | $22K | Buy |
+269
| New | +$22K | 0.01% | 229 |
|